OrganiGram (OGI) Status Update summary
Event summary combining transcript, slides, and related documents.
Status Update summary
29 Nov, 2025Market context and company positioning
Cannabis sector has seen significant share price declines, with major Canadian players down 61% over the past year.
Despite industry headwinds, the company has matured, expanded, and maintained a focus on innovation and consumer needs.
The company is now the largest Canadian LP by market share and recreational net revenue, operating five advanced facilities.
Strategic growth and operational excellence
Major acquisitions, including Motif Labs and Collective Project, have expanded product offerings and market reach.
Investments in automation, capacity, and R&D have driven cost reductions and efficiency gains, with CAD 10 million in annual cost savings identified.
International expansion is a key focus, with exports to Australia, Germany, and the UK, and a $21 million investment in Germany's Sanity Group.
Brand leadership and innovation
Portfolio includes leading brands like Shred, Boxhot, and Edison, with Shred generating $224 million in annual retail sales.
Innovation is driven by a proprietary seed-to-brand platform, seed-based cultivation, and science-backed product development.
Nano-emulsion technology enables faster onset and higher potency in edibles and beverages, supporting new product launches.
Latest events from OrganiGram
- Record revenue and EBITDA driven by Sanity Group and Canadian market strength, with rising global sales.OGI
Q3 2026 - Q2 revenue fell 9%, but European expansion and Sanity deal support FY26 revenue above $350M.OGI
Q2 2026 - Q1 net revenue grew 49% with strong margins, profitability, and Canadian market leadership.OGI
Q1 2026 - Record revenue, strong global expansion, and innovation drive leadership in cannabis.OGI
Investor Presentation - Record revenue, margin gains, and global expansion drive growth, with U.S. regulatory risks ahead.OGI
Q4 2025 - Motif deal, revenue gains, and global expansion make the company Canada's cannabis market leader.OGI
Q4 2024 - Returned to profitability with 25% revenue growth and expanded global footprint.OGI
Q3 2024 - Record revenue, margin gains, and global expansion drive strong Q2 performance.OGI
Q2 2025 - Net revenue up 17% and Motif acquisition drive market leadership and global expansion.OGI
Q1 2025